- Historical and cultural context of psychedelic use
- Structure of psychedelic-assisted therapy approaches
- Promises and pitfalls for the public to consider
- Approach to ketamine-assisted-psychotherapy
- The projected timeline of MDMA-assisted psychotherapy
Center Psychotherapy states that it is “committed to providing quality and expert mental health treatment using a humanist, client-centered approach to therapy. Its clinicians recognize that successful treatment varies with individual needs, strengths and personal client preferences. It strives to work with clients to develop treatment plans and therapeutic interventions that recognize strengths, not just symptom expression. The team is committed to anti-racism work, cross-cultural responsiveness, humility, sensitivity and responsibility. It supports BIPOC and LGBTQ+ communities, and it believes that collaboration is crucial in the treatment space.”
According to recent news reports, a panel of advisers to the Food and Drug Administration this month recommended against using MDMA in psychotherapy, but the FDA is expected to make its own ruling, possibly as soon as August.
Dec. 21, 2022: Local therapist attains MDMA certification, hopes to help those with PTSD in future
This announcement was published on Thursday, June 20, 2024, based on information from Zonya Dawson of Center Psychotherapy. It was updated June 22 to include a link to a news story on an anticipated FDA ruling on MDMA. It was updaed June 28 to note that the event had taken place.
